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Abstract 
 
Inference of the structural and functional consequences of amino acid-altering missense 
variants is challenging and not yet scalable. Clinical and research applications of the colossal 
number of identified missense variants is thus limited. Here we describe the aggregation and 
analysis of large-scale genomic variation and structural biology data for 1,330 disease-
associated genes. Comparing the burden of 40 structural, physicochemical, and functional 
protein features of altered amino acids with 3-dimensional coordinates, we found 18 and 14 
features that are associated with pathogenic and population missense variants, respectively. 
Separate analyses of variants from 24 protein functional classes revealed novel function-
dependent vulnerable features. We then devised a quantitative spectrum, identifying variants 
with higher pathogenic variant-associated features. Finally, we developed a web resource 
(MISCAST; http://miscast.broadinstitute.org/) for interactive analysis of variants on linear and 
tertiary protein structures. The biological impact of missense variants available through the 
webtool will assist researchers in hypothesizing variant pathogenicity and disease trajectories.  
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Recent advances in technologies have ushered in an era of rapid and cost-effective genome 
and exome sequencing. Genetic screening is now frequently applied in clinical practice, 
especially for the diagnosis of rare diseases and cancer, producing a plethora of benign and 
disease-associated genetic variants1,2. A large fraction of these clinically-derived variants has 
been captured in databases such as OMIM3, HGMD4, and ClinVar5. Simultaneously, millions of 
likely-benign or mildly disease-influencing variants from the general population have been 
cataloged and are accessible through the Exome Aggregation Consortium (ExAC)6 and in the 
genome Aggregation Database (gnomAD)7. Missense variation causes an amino acid 
substitution upon a single nucleotide variation in the protein-coding region of the genome. 
Missense variants can be either benign or disease-causing, and both types coexist in almost 
every human disease gene6. This underscores that functional interpretation of missense 
variants is particularly difficult, and some specific amino acid residues and their positions are 
essential for protein function and thus are vulnerable to substitutions. Exome sequencing 
studies can identify such protein-altering missense variants; however, the missing knowledge 
about the consequence of missense variants on protein function severely limits the 
interpretation of clinical genetic screening, and our understanding of how a missense variant is 
implicated in a disease phenotype. 
Current algorithms for variant interpretation incorporate numerous annotations to assess 
the pathogenicity of missense variants, including the conservation of sequences through 
evolution8-10, human population variation information11, and protein structural information12,13. 
With the latest explosion of genetic variant data, machine learning algorithms can learn and 
predict variant pathogenicity with reasonable accuracy14,15. However, variant pathogenicity 
predictions, combined from multiple in silico tools, represent only one piece of supporting 
evidence (referred to as PP316) in the variant interpretation guidelines as proposed by American 
College of Medical Genetics and Genomics (ACMG). This is primarily because of the similar 
underlying biases in these algorithms’ prediction outputs16, resulting from the use of similar 
.CC-BY 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/693259doi: bioRxiv preprint first posted online Jul. 4, 2019; 
 5 
variant sets. Further, the prediction scores do not provide biologically interpretable annotations 
that can be translated into possible variant-induced changes of underlying protein function. 
Studying the effect of disease-associated missense variation on the protein structure 
and function represents a growing research area. A damaging consequence of amino acid 
substitution has been found to be associated with the structural property and localization of the 
amino acid on protein structure17-19. Cluster analyses of patient variants and structural 
conservation analyses have shown that functionally essential amino acids and regions are not 
randomly distributed20-22. In separate research studies, missense variants were found to disrupt 
protein function by perturbing protein-protein interactions23, modifying functional residues24, 
destabilizing the entire protein fold25,26, or by substituting amino acid residues in protein 
cores27,28 and in protein-protein interfaces29-31. However, characterization of variants using a 
comprehensive set of protein features including physicochemical, functional, and 3D-structural 
features, for example, secondary structure types and protein-protein interactions, has not been 
performed using a common dataset and single, unified pipeline. Such a thorough 
characterization of disease-causing and benign missense variants would serve as a valuable 
resource for translational genetics, providing many structural and functional insights into the 
impact of an amino acid substitution.  
Functionally essential protein regions are shared among proteins performing similar 
molecular function. There is no study that provides a quantitative comparison of pathogenic and 
benign missense-variant-associated protein features across different protein functional classes. 
The current ACMG guidelines list the presence of variants in a mutational hot spot in less well-
characterized protein regions or in a critical functional domain that is depleted in population 
variants as a moderate criterion (referred to as PM1)16 for variant pathogenicity assessment. 
However, domain information may not be the only protein-based feature that can be used as a 
determinant of variant pathogenicity. Developing an inclusive annotation of structural, chemical, 
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and functional features for missense variants would be a powerful resource for the ACMG 
community. 
In this study, we investigate the features of amino acid residues altered by missense 
variants on protein structure at scale. First, we built an automated pipeline to map variants from 
genomic location to protein 3D structure location. Using the framework, we mapped >500,000 
missense variants in 5,850 genes onto >43,000 protein 3D structures from the protein data bank 
(PDB)32. The variant set was comprised of population missense variants from the gnomAD 
database7 and pathogenic missense variants from the ClinVar5 (pathogenic and likely-
pathogenic) and HGMD4 (disease mutation) databases. Second, we annotated the amino acid 
positions of these genes with a comprehensive set of seven protein features with forty feature 
subtypes. Third, we evaluated the burden of population and pathogenic missense variants in 
1,330 disease-associated genes on these forty features. To do so relative to protein function, 
we carried out separate analyses with variants in genes grouped into 24 protein classes based 
on their molecular function33. We validated the effectiveness of identified pathogenic and 
population missense variant-associated features on an independent variant set. Finally, we 
generated the Missense variant to proteIn StruCture Analysis web SuiTe (MISCAST; 
http://miscast.broadinstitute.org/). MISCAST contains feature annotations for each amino acid 
position of the 1,330 genes alongside a quantitative comparison with protein class-specific 
pathogenic and population missense-variant-associated features. MISCAST provides the most 
comprehensive catalog of protein-based features for missense variants and to date the only 
resource that gives protein class-specific characterization of missense variants. 
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Results 
Description of dataset 
In this study, we characterized missense variants with 3D coordinates in at least one protein 
structure using seven protein features of amino acid residues: (1) 3-class secondary structure, 
(2) 8-class secondary structure, (3) residue exposure level, (4) physicochemical property, (5) 
protein-protein interaction, (6) post-translational modification, and (7) UniProt-based functional 
features. These seven features further have forty subtypes (description of features in Methods 
and Supplementary Note). We performed the characterization jointly for all variants and 
independently for variants in groups of genes with similar molecular function. Initial collection of 
solved human protein structures from Protein Data Bank32 (accessed September 2017) resulted 
in 43,805 tertiary structures for 5,850 genes. For 5,724 genes, we found variants from the 
gnomAD database6 (hereafter referred to as population variants). For 1,466 and 1,673 genes, 
we obtained pathogenic and likely-pathogenic variants from ClinVar6 and disease mutations 
from HGMD6 databases, respectively (hereafter referred to as pathogenic variants). In total, we 
aggregated 1,485,579, 16,570 and 47,036 variants (unique amino acid alterations) from 
gnomAD7, ClinVar5 and HGMD4, respectively. Out of the available variants, 33% (count = 
496,869), 49.1% (count = 8,137), and 65.3% (count = 30,730) variants from gnomAD, ClinVar, 
and HGMD, respectively, were mappable to at least one protein structure from PDB. Population 
variants were mappable for 4,987 and pathogenic variants for 1,330 human genes. We 
restricted the data set to 1,330 genes with both population and pathogenic variants to perform 
an unbiased comparative analysis. The final dataset was comprised of 164,915 population 
variants and 32,923 pathogenic missense variants across 1,330 genes (Supplementary Table 
1), which were grouped into 24 protein classes (Supplementary Table 2, protein class 
ascertainment in Methods) to perform protein class-specific analysis. This missense variant and 
gene dataset are referred to as Disease-Associated Genes with Structure (DAGS1330) in this 
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study. The workflow of this study is briefly presented in Fig. 1 and the overview of the dataset is 
shown in Table 1. 
 
 
Fig. 1 | Flowchart of the study. Genetic variant to protein structure mapping pipeline, feature 
annotation and statistical analysis. 
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Table 1. Number of genes, genetic variants/amino acid alterations, protein structures in the dataset.  
 Population variants Pathogenic variants 
 gnomAD missense ClinVar missense 
(likely/-pathogenic) 
HGMD missense 
(disease mutation) 
Genes with protein 3D structure 5,724 1,466 1,673 
Number of amino acid alterations in the genes 
with protein 3D structure  
1,485,579 16,570 47,036 
Number of amino acid alterations mapped on 
the structure 
496,869 8,137 30,730 
Genes with variants mapped on the structure 4,897 1,330*,+ 
Number of unique 3D structures on which the 
variants were mapped 
29,870 14,270* 
Number of amino acid alterations in 
DAGS1330 genes that were mapped on the 
structure  
164,915+ 32,923*,+ 
*  combined (unique) counts from HGMD and ClinVar databases. 
+  Genes and variants that are considered in the final statistical analysis, referred to as Disease Associated Genes with Structure (DAGS1330). 
 
 
Feature patterns of population and pathogenic missense variants on protein 3D 
structure across all protein classes.  
Our understanding of which protein features are more likely to be disease relevant is still in its 
infancy. To identify structural, physiochemical, and functional protein features that are 
associated with pathogenic and population missense variants, we performed burden analysis 
with seven features including in total 40 subtypes (ascertainment and definition of features in 
Methods and Supplementary Note) across DAGS1330 genes. Fisher’s Exact test was 
performed for individual feature subtypes of the population and pathogenic variants, quantifying 
the fold-enrichment and significance of the association. Notably, out of the seven features, 
physiochemical properties of amino acid and UniProt-based functional features could be curated 
from the protein sequence only. However, our dataset comprised of the missense variants that 
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could be mapped on the protein 3D structure only, thus, the identified features depict the 
characteristics of variants on protein structure. All seven protein features showed a deviating 
distribution of population and pathogenic missense variants for at least one feature subtype. 
The direction of the association was heterogeneous across feature subtypes (Fig. 2). In total, 18 
out of 40 (45%) protein feature subtypes were significantly enriched for pathogenic variants. The 
UniProt-based functional protein features had the highest number of feature subtypes (5/6) that 
were enriched for pathogenic variants (Fig. 2). In contrast, 14 out of 40 (35%) feature subtypes 
showed significant depletion of pathogenic variants and enrichment of population variants. The 
physiochemical properties showed enrichment of population variants in six out of eight 
subtypes. Eight protein feature subtypes (20%) did not show any specific association to 
pathogenic or population variants. 
A wide range of effect sizes was observed for the enrichment of pathogenic variants 
across the 18 protein feature subtypes with odds ratio (OR) values ranging from 1.21 to 21.75 
(Fig. 2). The top three features associated with pathogenic variants were intermolecular 
disulfide bonds (OR = 21.75), SUMOylation sites (OR = 5.75), and O.GlcNAc sites (OR = 5.55). 
We further investigated for a possible bias in our analysis due to the wide range of population to 
pathogenic variant ratio per gene (0.02 – 156.0). When the analyses were repeated using only 
the identical number of variants per gene (20,552 pathogenic and 20,552 population variants in 
588 genes, details in Supplementary Note), the patterns of population and pathogenic 
missense-variant-associated features remained consistent for 35 out of 40 features, considering 
the direction of association (Supplementary Fig. 1). The major deviations compared to the full 
DAGS1330 dataset were the associations of salt-bridge ionic bond and hydrogen bond sites 
with pathogenic variants which were observed the opposite way for the full dataset (details in 
Supplementary Note). 
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Fig. 2 | Burden of pathogenic and population variants in protein features, taking 32,923 
pathogenic and 164,915 population variants in 1,330 genes. The plot shows results of the two-tailed 
Fisher’s Exact test for 40 feature subtypes. The y-axis outlines the feature names, followed by the feature 
counts with and without (yes/no) pathogenic and population variants, the odds ratio (OR) and the 
significance (p-value). The squares (brown) show the OR and the bars (blue) show the 95% confidence 
interval on the x-axis. OR=1 indicates the neutral value (no enrichment or depletion) while the OR > 1.0 
(and < 1.0) indicates enrichment of pathogenic variants (and population variants). If the association is 
significant (p-value < pcut-off = 5.0e-05), the corresponding p-value is followed by (*), otherwise (-). For 
protein-protein interaction types, the feature counts correspond to all bond-annotations available for the 
amino acid residues with pathogenic and population variants. For the rest of the features, the counts 
correspond to the number of amino acid residues. 
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Feature patterns of protein class-specific population and pathogenic missense 
variants on protein 3D structure.  
Proteins are heterogenous in function and structure. We next explored if the features of 
pathogenic and population variants obtained from the full DAGS1330 dataset were consistent 
across different protein classes, having heterogenous molecular functions (see Methods for 
protein class ascertainment, Supplementary Table 2 for protein class-specific genes and 
variant counts, Supplementary Fig. 2 – 8 for protein class-specific Fisher’s Exact test outputs, 
and Table 2 for the summary of the results). Through the protein functional class-specific 
analyses, we aim to capture both shared and unique function-specific features of pathogenic 
and population variants on protein structure.    
We observed that pathogenic variants are enriched in β-strand/sheet residues for 20 out 
24 of protein classes (Supplementary Fig. 2a and 3b). This observation is consistent with the 
joint analysis with full DAGS1330 dataset (Fig. 2). In contrast, cell junction proteins displayed a 
deviating characteristic with enrichment of population variants in β-strand/sheet (OR = 0.37, p = 
1.40e-13, Supplementary Fig. 2a), specifically, β-sheet (OR = 0.35, p = 3.91e-14, in 
Supplementary Fig. 3b). Moreover, pathogenic variants of cell adhesion molecules were 
significantly frequent in both stable β-sheet residues (OR = 1.72, p = 7.52e-25, Supplementary 
Fig. 3b) and flexible coils, specifically, random loops (OR = 1.28, p = 3.67e-06, Supplementary 
Fig. 3f), and bends (OR = 1.35, p = 2.19e-05, Supplementary Fig. 3g). The enrichment of 
pathogenic variants followed a negative gradient of exposure levels of amino acids (Fig. 2) and 
was consistent for the majority of the protein classes (Supplementary Fig. 4). Amino acid 
residues in the interior of the 3D structure with < 25% relative accessible surface area (RSA) 
were enriched with pathogenic variants (Supplementary Fig. 4a-b), whereas the residues with 
≥ 25% RSA were enriched with population variants (Supplementary Fig. 4c-e). Among 
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physiochemical property-based groups of amino acids, pathogenic variants were observed 
significantly more frequent on aromatic (tryptophan, tyrosine, phenylalanine) amino acids in 23 
out of 24 protein classes, as well as on special amino acids (cysteine, proline, glycine) in all 24 
protein classes (Supplementary Fig. 5c and 5h). Specifically, the cell adhesion molecules, 
transcription factors, phosphatases, and signaling molecule proteins carried greater than 2-fold 
enrichments of pathogenic variants changing an aromatic amino acid. At positions of special 
amino acids, calcium-binding and extracellular matrix proteins showed enrichments of 
pathogenic variants with OR > 3.0 (p < 1.0e-100). 
 The inter-chain disulfide bond had the strongest enrichment in the joint analysis (OR = 
21.75, p < 1.0e-100, Fig. 2). While such an association has been demonstrated 27, our protein 
class-specific analysis revealed that the enrichment was primarily directed by pathogenic 
variants from three protein classes alone (Supplementary Fig. 6a). In contrast, the non-bonded 
van der Waals interaction sites were enriched with pathogenic variants from all protein classes 
except phosphatases and nucleic acid binding proteins (Supplementary Fig. 6d). The 
pathogenic variants in kinases, nucleic acid binding and cytoskeletal proteins were found more 
frequent on salt-bridge and hydrogen bond sites (Supplementary Fig. 6c-d), which are protein 
class-specific features as these sites were found depleted of pathogenic variants for the full set 
(Fig. 2). Heterogeneous patterns of association between missense variants and post-
translational modification (PTM) types were observed across different protein classes 
(Supplementary Fig. 7). The amino acid residues near phosphorylation sites were found to be 
enriched with pathogenic variants in joint analysis (Fig. 2); however, a differential pattern was 
observed for hydrolases (OR = 0.80, p = 7.29e-11) and cell adhesion molecules (OR = 0.58, p = 
3.81e-15) with significant depletion of pathogenic variants around phosphorylation sites 
(Supplementary Fig. 7d). The cell junction proteins pathogenic variants showed an enrichment 
around methylation sites (OR = 9.10, p = 9.29e-11, Supplementary Fig. 7b), whereas there 
was no significant association observed for the full dataset. For nine out of twenty-four protein 
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classes, we observed significant enrichment of population variants around ubiquitination sites; 
however, the trend was different for transcription factors (OR = 1.44, p = 1.77e-06) and 
extracellular matrix proteins (OR = 2.05, p = 2.51e-05), with an enrichment of pathogenic 
variants around ubiquitination sites (Supplementary Fig. 7f). Modular domains and modified 
residues were identified as shared functional features for a majority of the protein classes, 
twenty-three and twenty-two, respectively, out of twenty-four classes (Supplementary Fig. 8). 
The pathogenic variants of transporters, kinases, transcription factors, and nucleic acid binding 
proteins were observed to be associated with functional sites, binding regions and sequence 
motifs. The protein class-specific analysis also showed that only the transfer/carrier protein (OR 
= 8.90, p = 3.68e-09) and enzyme modulator (OR = 3.09, p = 6.20e-10) carry enrichment of 
pathogenic variants on protein regions involved in molecular processing and signaling 
(Supplementary Fig. 8d); however, we observed no association with this feature collectively for 
the full variant set (Fig. 2).  
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Table 2. Protein-class-specific pathogenic and population missense variant-associated features. 
Here, the columns are for seven different protein features where each cell outlines the feature subtypes 
that had significant burden of pathogenic and population variants (two-tailed Fisher’s Exact test, p < pcut-
off, 5.0e-05). The ‘✘’ indicates that no subtype of the corresponding protein feature was significantly 
associated with any variant type.  
Pathogenic missense variant-associated features 
Protein class 3-class 
secondary 
structure  
8-class 
secondary 
structure  
Residue 
exposure 
levels 
Physio 
chemical 
properties of 
amino acid 
Protein-
protein 
Interactions 
Post-
translational 
modification 
types 
UniProt-based 
functional 
features 
All classes  b-
strand/sheet 
b-sheet,  
p-helix 
core, 
buried 
aromatic,  
special 
disulfide, 
nonbonded 
Van der 
Waals 
acetylation,  
O.GlcNAc, 
phosphorylation,  
SUMOylating  
functional site, 
functional/Binding 
region, sequence 
motif/region, 
modular domain, 
modified residue 
Calcium-Binding 
Protein 
✘ ✘ core, 
buried 
special nonbonded 
Van der 
Waals 
✘ functional/binding 
region, modular 
domain 
Cell Adhesion 
Molecule 
b-
strand/sheet, 
coils 
b-sheet, 
coil-loop, 
coil-bend 
core, 
buried 
aromatic,  
special 
nonbonded 
Van der 
Waals 
✘ functional site, 
modular domain, 
modified residue 
Cell Junction 
Protein 
helices a-helix,  
p-helix 
core ✘ nonbonded 
Van der 
Waals 
methylation functional site, 
modular domain 
Chaperone ✘ ✘ ✘ ✘ salt-bridge, 
nonbonded 
Van der 
Waals 
✘ sequence 
motif/region, 
modular domain 
Cytoskeletal 
Protein 
✘ ✘ core ✘ salt-bridge, 
hydrogen, 
nonbonded 
acetylation, 
phosphorylation, 
SUMOylating 
function/Binding 
region, modular 
domain 
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Van der 
Waals 
Defense/ 
Immunity Protein 
coils ✘ core aromatic,  
special 
✘ ✘ sequence 
motif/region, 
modified residue, 
modular domain 
Enzyme 
Modulator 
✘ ✘ core aromatic,  
special 
salt-bridge, 
nonbonded 
Van der 
Waals 
✘ functional site, 
functional/Binding 
region, modular 
domain, modified 
residue, 
molecular 
processing-
associated region 
Extracellular 
Matrix Protein 
✘ ✘ core, 
buried 
special hydrogen, 
nonbonded 
Van der 
Waals 
acetylation, 
SUMOylating, 
ubiquitination 
functional site, 
sequence 
motif/region, 
modified residues 
Hydrolase b-
strand/sheet 
 b-sheet,  
b-strand, 
coil-bend 
core aromatic,  
special 
disulfide, 
salt-bridge, 
nonbonded 
Van der 
Waals 
✘ functional site, 
modified residue, 
modular domain 
Isomerase b-
strand/sheet 
 b-sheet core ✘ salt-bridge, 
nonbonded 
Van der 
Waals 
✘ modular domain 
Kinase helices a-helix core, 
buried 
aromatic,  
special 
salt-bridge, 
hydrogen, 
nonbonded 
Van der 
Waals 
phosphorylation, 
SUMOylating 
functional site, 
functional/Binding 
region, sequence 
motif/region, 
modified residue, 
modular domain 
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Ligase b-
strand/sheet 
b-sheet core aromatic,  
special 
nonbonded 
Van der 
Waals 
phosphorylation, 
SUMOylating 
function/Binding 
region, modular 
domain 
Lyase ✘ ✘ core ✘ nonbonded 
Van der 
Waals 
✘ modular domain 
Membrane Traffic 
Protein 
b-
strand/sheet 
b-sheet ✘ ✘ nonbonded 
Van der 
Waals 
✘ sequence 
motif/region, 
modified residue, 
modular domain 
Nucleic Acid 
Binding 
helices a-helix core, 
buried 
aromatic,  
 
special 
Salt-bridge, 
hydrogen 
phosphorylation functional site, 
functional/Binding 
region, sequence 
motif/region, 
modular domain 
Oxidoreductase b-
strand/sheet 
b-sheet core, 
buried 
aromatic, 
special 
nonbonded 
Van der 
Waals 
SUMOylating functional site, 
functional/Binding 
region, modular 
domain 
Phosphatase ✘ ✘ core aromatic ✘ acetylation, 
phosphorylation, 
SUMOylating 
sequence 
motif/region, 
modular domain 
Protease b-
strand/sheet 
b-sheet,  
p-helix 
core, 
buried 
aromatic,  
special 
disulfide, 
salt-bridge, 
hydrogen, 
nonbonded 
Van der 
Waals 
✘ modified residue, 
modular domain 
Receptor b-
strand/sheet 
b-sheet core, 
buried 
aromatic,  
special 
nonbonded 
Van der 
Waals 
✘ functional site, 
sequence 
motif/region, 
modified residue, 
modular domain 
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Signaling 
Molecule 
b-
strand/sheet 
 b-sheet core, 
buried 
aromatic,  
special 
disulfide, 
nonbonded 
Van der 
Waals 
✘ modified residue, 
modular domain 
Transcription 
Factor 
helices a-helix core, 
buried 
aromatic,  
special 
nonbonded 
Van der 
Waals 
phosphorylation, 
ubiquitination 
functional site, 
functional/Binding 
region, sequence 
motif/region, 
modular domain 
Transfer/Carrier 
Protein 
✘ p-helix core, 
buried 
special nonbonded 
Van der 
Waals 
acetylation,  
O.GlcNAc, 
phosphorylation 
sequence 
motif/region, 
modular domain, 
modified residue, 
molecular 
processing-
associated region 
Transferase b-
strand/sheet 
b-sheet core, 
buried 
aromatic,  
special 
salt-bridge, 
hydrogen, 
nonbonded 
Van der 
Waals 
phosphorylation, 
SUMOylating 
functional site, 
functional/Binding 
region, modified 
residue, modular 
domain 
Transporter helices a-helix core special hydrogen, 
nonbonded 
Van der 
Waals 
acetylation, 
O.GlcNAc, 
phosphorylation 
functional site, 
functional/Binding 
region, sequence 
motif/region, 
modified residue, 
modular domain 
 
Population missense variant-associated features 
 
3-class 
secondary 
structure 
types 
8-class 
secondary 
structure 
types 
Residue 
exposure 
levels 
Physiochemical 
properties 
Interaction 
types 
Post-
translational 
modification 
types 
Uniprot-based 
functional 
features 
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All classes helices, coils 310-helix, 
coil-turn 
medium-
buried, 
medium-
exposed, 
exposed 
hydrophobic, 
aliphatic,  
polar,  
neutral 
salt-bridge, 
hydrogen 
ubiquitination ✘ 
Calcium-Binding 
Protein 
✘ ✘ medium-
buried, 
medium-
exposed, 
exposed 
aliphatic,  
polar,  
positively-
charged,  
neutral 
hydrogen acetylation, 
ubiquitination 
✘ 
Cell Adhesion 
Molecule 
helices a-helix medium-
buried, 
medium-
exposed 
aliphatic,  
polar,  
positively-
charged, 
neutral 
hydrogen acetylation, 
phosphorylation, 
ubiquitination 
functional/Binding 
region, sequence 
motif/region 
Cell Junction 
Protein 
b-
strand/sheet 
b-sheet medium-
buried, 
medium-
exposed 
✘ ✘ ✘ sequence 
motif/region 
Chaperone ✘ ✘ ✘ ✘ ✘ ✘ ✘ 
Cytoskeletal 
Protein 
✘ ✘ medium-
exposed 
neutral ✘ ✘ ✘ 
Defense/Immunity 
protein 
helices a-helix medium-
exposed 
hydrophobic, 
aliphatic, polar, 
positively-
charged, 
neutral 
✘ ✘ ✘ 
Enzyme 
Modulator 
✘ ✘ medium-
buried, 
medium-
exposed, 
exposed 
polar,  
negatively-
charged, 
neutral 
✘ ubiquitination ✘ 
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Extracellular 
Matrix Protein 
✘ ✘ medium-
buried, 
medium-
exposed 
hydrophobic, 
aliphatic, polar, 
positively-
charged, 
neutral 
✘ ✘ molecular 
processing-
associated region 
Hydrolase helices a-helix, 
coil-turn 
medium-
buried, 
medium-
exposed, 
exposed 
aliphatic,  
polar,  
neutral 
✘ methylation, 
phosphorylation, 
ubiquitination 
sequence 
motif/region, 
molecular 
processing 
Isomerase ✘ ✘ medium-
buried, 
medium-
exposed 
✘ ✘ acetylation ✘ 
Kinase coils coil-turn medium-
buried, 
medium-
exposed, 
exposed 
polar, neutral ✘ ✘ molecular 
processing-
associated region 
Ligase helices a-helix medium-
buried, 
medium-
exposed 
✘ salt-bridge ubiquitination ✘ 
Lyase ✘ ✘ medium-
buried, 
medium-
exposed 
✘ salt-bridge, 
hydrogen 
✘ sequence 
motif/region 
Membrane Traffic 
Protein 
✘ ✘ ✘ ✘ ✘ ✘ ✘ 
Nucleic Acid 
Binding 
coils ✘ medium-
buried, 
medium-
exposed, 
exposed 
aliphatic,  
polar,  
neutral 
nonbonded 
Van der 
Waals 
✘ ✘ 
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Oxidoreductase ✘ ✘ medium-
buried, 
medium-
exposed 
aliphatic,  
polar,  
neutral 
hydrogen ✘ ✘ 
Phosphatase ✘ coil-turn medium-
buried, 
medium-
exposed, 
exposed 
neutral hydrogen, 
nonbonded 
Van der 
Waals 
ubiquitination ✘ 
Protease helices a-helix medium-
buried, 
medium-
exposed 
aliphatic,  
polar,  
positively-
charged, 
neutral 
✘ ubiquitination molecular 
processing-
associated region 
Receptor helices coil-turn medium-
buried, 
medium-
exposed, 
exposed 
aliphatic,  
polar,  
positively-
charged, 
neutral 
hydrogen ✘ ✘ 
Signaling 
Molecule 
helices 310-helix,  
a-helix, 
coil-turn 
medium-
buried, 
medium-
exposed, 
exposed 
aliphatic,  
polar,  
positively-
charged, 
negatively-
charged, 
neutral 
salt-bridge, 
hydrogen 
ubiquitination sequence 
motif/region 
Transcription 
Factor 
coils coil-loop, 
coil-bend 
medium-
buried, 
medium-
exposed, 
exposed 
polar,  
negatively-
charged, 
neutral 
✘ ✘ ✘ 
Transfer/Carrier 
Protein 
✘ ✘ medium-
exposed, 
exposed 
aliphatic, 
neutral 
salt-bridge, 
hydrogen 
✘ functional site 
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Transferase coils coil-turn medium-
buried, 
medium-
exposed, 
exposed 
aliphatic,  
 
 
polar, neutral 
✘ ubiquitination molecular 
processing-
associated region 
Transporter coils coil-bend medium-
buried, 
medium-
exposed 
aliphatic salt-bridge ✘ molecular 
processing-
associated region 
 
 
Validation of MISCAST annotation  
We developed an online resource for exploration of the generated data named Missense variant 
to proteIn StruCture Analysis web SuiTe (MISCAST; http://miscast.broadinstitute.org/). 
MISCAST includes interactive visualization of features and variants on linear and 3D protein 
structure (Fig. 3a), amino-acid-wise feature annotations (Fig. 3b), and protein class-specific 
features of pathogenic and population variants (Fig. 3d). In addition, through MISCAST, the 
users can obtain amino-acid-wise variant summary reports that can assist in rationalizing the 
pathogenicity of variants according to features of the reference amino acid. We expect that 
amino acid substitutions that have a deleterious impact on protein structure and function have 
greater numbers of pathogenic variant-associated protein features (found significant in the 
association analysis after Bonferroni correction). Vice versa, benign population variants are 
presumed to have greater numbers of population variant-associated features. To test this 
hypothesis, we devised a single spectrum per amino acid defined by the difference of the 
number of pathogenic and population variant-associated features, termed as MISCAST feature 
difference spectrum (MISCAST-fdspec). The positive values in MISCAST-fdspec (an example is 
shown in Fig. 3c) indicate comparatively higher pathogenic variant-associated features whereas 
the negative values represent relatively higher population variant-associated features. The 
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MISCAST-fdspec score per amino acid of a gene can be computed taking all class-specific or 
protein class-specific pathogenic and population variant-associated features.  
An independent validation set, comprised of 18,094 pathogenic and likely-pathogenic 
variants (referred as PLP) and 9,222 benign and likely-benign (referred as BLB) variants (see 
Methods for validation set preparation) in 1,286 genes, showed differential distribution of PLP 
and BLB variants in all class-specific MISCAST-fdspec bands (Fig. 4a) with a 3.6-fold 
enrichment of PLP variants (p < 2.2e-16) in the positive bands. Separate evaluations of 
independent variants in 249 nucleic acid binding proteins and 208 transferases also show 
opposite distribution of PLP and BLB variants along protein class-specific MISCAST-fdspec, 
resulting in 2.43-fold (Fig. 4b, p = 2.43e-37) and 2.92-fold (Fig. 4c, p = 1.96e-30) enrichment of 
PLP variants in the positive bands, respectively. Finally, as another independent approach to 
show the utility of our newly generated protein feature annotation, we evaluated readouts from 
high-throughput mutagenesis for BRCA134 and PTEN35 (details in Supplementary Note). 
Missense variants leading to loss-of-function of BRCA1 were 5.14-fold more enriched (p = 
1.13e-22) in positive bands of nucleic acid binding protein class-specific MISCAST-fdspec 
(Supplementary Fig. 9a). We also show that functionally-verified damaging missense variants 
in PTEN are 6-fold enriched (p = 3.58e-40) in positive MISCAST-fdspec bands, specific to the 
phosphatase protein-class (Supplementary Fig. 9b).   
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Missense variant to proteIn StruCture Analysis web SuiTe (MISCAST) 
 
 
 
           
Fig. 3 | Overview of Missense variant to ProteIn StruCture Analysis web SuiTe (MISCAST). a, MISCAST 
3D viewer with pathogenic (red) and population (blue) variants in the CDKL5 gene (Cyclin-dependent kinase-like 
5) mapped on its corresponding protein structure (PDB: 4bgq). An additional reference amino acid Tyr262 is 
highlighted in magenta for further analysis in this overview. Features (not shown in this figure) and variants can 
be visualized in 1D and 3D protein structure through MISCAST and are freely downloadable for offline analysis. 
b, Structural, physicochemical and functional feature annotations for Tyr262, available in MISCAST. c, 
Quantitative comparison of protein class-specific pathogenic and population-variant-associated feature counts 
for Tyr262, which are 6 and 0, respectively, shown (magenta circle) on the distribution of feature counts obtained 
by in-training pathogenic and population variant set. Thus, for Tyr261, MISCAST-fdspec is equal to 6 – 0 = 6. A 
positive MISCAST-fdspec indicates that Tyr262 possesses higher variant vulnerability. d, Besides quantitative 
comparison, user can check the original features of Tyr262 that were matched with the protein function-specific 
features to hypothesize the molecular consequence of the Tyr262 substitution.    
 
●
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pathogenic population Features of  reference amino acid: Tyr/Y262 Pathogenic variant-associated 
features of  kinases
Population variant-associated 
features of  kinases
1. 3-class secondary structure: helix helix coils
2. 8-class secondary structure: α-helix α-helix coil-turn
3. Exposure to solvent: core core, buried core, buried
4. Physiochemical property: aromatic aromatic, special medium-buried, medium-
/exposed
5. Protein-protein interaction: none salt-bridge ionic, hydrogen and 
nonbonded Van der Waals
none
6. Post-translational modification: phosphorylation Phosphorylation, sumoylation none
7. UniProt-based functional features: modular domain functional sites, 
functional/binding regions, 
sequence motif/regions, modified 
residues and modular domain
Molecular-processing-
associated region
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Features of amino acid residue: Tyrosine (Tyr/Y) at position 262 
1. 3-class secondary structure: helix 
2. 8-class secondary structure: α-helix 
3. Exposure to solvent: core (<5% relative solvent accessibility) 
• solvent accessible surface area: 3 Å2 
4. Physiochemical property: hydrophobic & aromatic amino acid 
5. Protein-protein interactions: no protein complex structure available 
6. Distance to post-translational modification sites on 3D structure: 
• Acetylation: 
o 4bgq:A, structure position: 33, distance to Y262: 49.912Å 
• Phosphorylation: 
o 4bgq:A, structure position: 262, distance to Y262: 0.0Å 
7. UniProt-based functional features: 
• Modular domain: F13-F297 (Protein kinase) 
b 
d 
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a 
 
b 
 
c 
 
Enrichment of PLP variants in positive MISCAST−fdspec:
3.6−fold, p < 2.20e−16
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Fig | 4. Validation of MISCAST-fdspec using clinically-ascertained independent variant set. a, 
Proportion of pathogenic and likely-pathogenic variants from ClinVar and disease mutations from HGMD 
in 1,286 genes (referred as PLP), independent from the training set, and benign and likely-benign variants 
from ClinVar (referred as BLB) in different MISCAST-fdspec bands, quantifying the difference between the 
number of pathogenic- and population-variant-associated features. The most confident positive MISCAST-
fdspec band (> 2) contains 4.9-times more PLP than BLB variants and that of confident negative MISCAST-
fdspec band (> 2) contains 4.2-times more BLB and PLP variants. b, Proportion of PLP and BLB variants 
in 249 nucleic acid binding genes in different MISCAST-fdspec bands, computed based on nucleic acid 
binding protein class-specific features. c, Proportion of PLP and BLB variants in 208 transferase genes in 
different MISCAST-fdspec bands, computed based on nucleic acid binding protein class-specific features. 
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Discussion 
Here, we investigated forty different structural, physiochemical, and functional features of amino 
acids altered by missense variants in 1,330 genes upon mapping of the variants onto 3D protein 
structures. We compared the burden of the population (gnomAD7) and pathogenic (combined 
ClinVar5 and HGMD36) variants in these forty features. As expected, pathogenic and population 
variants showed distinct distributions for many protein features. By joint analysis on all variants 
in 1,330 genes, we found eighteen pathogenic- and fourteen population variant-associated 
protein features. Additionally, separate analyses on variants in genes of different protein 
functional classes resulted in novel class-specific features of pathogenic and population 
missense variants. We further derived a spectrum of differences between the number of 
pathogenic and population variant-associated features for missense variants using the study 
outcome, referred as MISCAST-fdspec. We expect deleterious missense variants to possess 
positive MISCAST-fdspec values and evaluate the method using ClinVar-ascertained and 
experimentally-annotated validation sets.  
 A large number of publicly available disease-associated missense variants is available; 
however, a vast majority of these variants are of uncertain significance5, which fundamentally 
limits the clinical and research utility of genetic variation information. Given the complexity of 
variant classification, statistical approaches to objectively hypothesize the functional 
consequence of missense variants is pivotal16. MISCAST will play a key role here, as it 
characterizes missense variants on experimentally solved protein structures, providing function-
specific features and structural insights into the effect of missense variants at the molecular 
level, going beyond sequence- and conservation-based methods alone. It’s also worth noting 
that while the presence of variants in functional important protein domains has been widely 
utilized for variant interpretation37,38, MISCAST further considers critical structural and 
physicochemical features of the amino acid that may have functional implications on the protein 
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structure and function upon perturbation. For reference, in our dataset, 28.3% of the pathogenic 
variants are not located in any protein domain according to UniProt annotation. Thus, MISCAST 
provides a comprehensive summary of vulnerability to structural, functional, and chemical 
impacts of substitutions, specifically, by reporting the original biological features to be altered 
along with the quantitative scoring (an illustrative overview of MISCAST in Fig. 3).  
Our statistical analyses confirmed established association signatures between missense 
variants and protein features that have been found on a smaller scale and also illuminated novel 
protein class-specific signatures. For example, we observed an enrichment of pathogenic 
variants in β-strands/sheets conformation (Fig. 2) for all genes, thereby confirming the previous 
result that β-strands/sheets are more variant-intolerant and vulnerable to stabilization compared 
to helices upon sequence changes39. However, we found novel protein class-specific 
associations, such as pathogenic variants being significantly enriched on α-helices for five 
protein classes (Supplementary Fig. 3d). In cell junction proteins (OR = 10.54), transfer/carrier 
proteins (OR = 3.58), and proteases (OR = 2.71), pathogenic variants were more likely to 
mutate π-helix residues. The π-helical regions have been shown to undergo selection and often 
provide a functional advantage to proteins40,41; therefore, pathogenesis upon altering π-helices 
may be associated with perturbation of the protein functions. The protein core (Relative Solvent 
Area, RSA < 5%) is found to be a uniform descriptor of variant pathogenicity for all protein 
classes (Supplementary Fig. 4a), which is in line with established literature as well27. At the 
same time, for twenty-one out of twenty-four protein classes, distributions of RSA values for 
pathogenic missense variants showed higher maximum RSA values and accumulate a higher 
number of outliers (Supplementary Fig. 10). This result indicates the presence of pathogenic 
variants on the protein-protein surface31 that may perturb essential interaction sites by altering 
exposed residues.   
 On protein structure, the special amino acids cysteine (Cys, OR = 3.84, p < 1.00e-100) 
and glycine (Gly, OR = 1.76, p < 2.19e-154) were found to be predominantly mutated by 
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pathogenic missense variation (Supplementary Fig. 11). The enrichment for Cys residues 
correlates well with the cogent association between variant pathogenicity and perturbation of 
covalent disulfide bond (a structure-based pathogenic-variant-associated feature), as a Cys 
mutation is likely to impair such a bond27. However, there is a protein class-specific bias in the 
available disulfide bond annotations42 (Supplementary Fig. 6a). Specifically, 93.8% 
(3,642/3,879) of the disulfide bonds affected by a pathogenic variant were found in genes that 
encode for proteins transducing signals between cells. The other special amino acid, Gly, is the 
smallest amino acid having no side chain and is usually flexible. Greater than 67% of the Gly 
residues in our variant set is pliable coils and their substitutions by a larger amino acid is likely 
to have an impact on structure due to steric clashes23. All aromatic residues were found 
enriched for pathogenic variants (Fig. 2), with tryptophan (Trp) having the strongest association 
(OR = 3.27, p = 2.88e-126). Trp is the largest amino acid and it has also been shown that Trp 
mutations lead an increase in free energy of protein folding, making them more likely to 
destabilize the structure of protein27. Arginine (Arg) was also found to have a burden of 
pathogenic variants31 (Supplementary Fig. 11), while the other positively-charged amino acids 
(lysine and histidine) were found to be associated with population variants.  
Pathogenic variants were, in general, found to spatially cluster near different post-
translational modification (PTM) sites43; however, we identified several protein class-specific 
novel signatures. For example, the pathogenic variants in transcription factors, extracellular 
matrix proteins, and structural proteins were found to be enriched near ubiquitination sites 
(Supplementary Fig. 8f), which were found depleted of pathogenic variants by joint analysis 
(Fig. 2). Kinases alone carried 15% and 56% of the pathogenic variants near phosphorylation 
and SUMOylation sites. Expanding the six UniProt-based functional features into twenty-five 
constituent features (details in Supplementary Note), we identified twenty-one pathogenic 
variant-associated features. While some of these features, such as modular domains44, motifs, 
and binding sites43, are known to be associated with pathogenic variants, our study revealed 
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new associations. A burden of pathogenic variants (OR = 3.9, p < 1.0e-100, Supplementary 
Fig. 12) on residues annotated by at least one functional feature versus no feature was also 
notable, showing putative association between variant pathogenicity and protein function.  
It is important to note that we characterized the protein positions of missense variants 
that were mappable onto at least one protein 3D structure available in PDB32, which includes 
structures for only one-third of all human proteins. Many of these structures have partial 
coverage of the protein. Therefore, our study outcomes are not exclusive of the influence that 
may come from accounting for the structured part of the full protein sequence. Also, we could 
transfer a higher proportion of pathogenic variants (~60%) compared to the population variants 
(~33%) onto protein structure. Out of the 1,330 disease-associated genes (>80%, n = 1,077 
annotated in OMIM), >55% of the genes had at least one structure with >50% of the sequence 
covered in the structure, and >75% of the ClinVar and HGMD pathogenic variants could be 
mapped onto the structure for those genes. This observation is consistent with the positive 
correlation observed between the number of known variants in proteins and the number of 
proteins being molecularly solved and reported in the literature45.  
While performing the protein class-specific analyses, we also observed issues due to 
having smaller variant sets that could be mapped on the 3D structures. For one (lyase) and four 
(chaperons, cytoskeletal protein, defense/immunity proteins and membrane-traffic proteins) 
protein classes, we found three or fewer pathogenic- and population-variant-associated features 
(Table 2), respectively, after applying the stringent significance cut-off. In addition, the power of 
the MISCAST-fdspec metric is affected by unavailability of 3D structure information of a 
reference amino acid, as, in that case, the quantitative score is computed based on the 
physicochemical and functional features only. In future work, we plan to include high-fidelity 
homology models and computational models of protein structures to scale up the generated 
resource to the full human proteome. 
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Currently, a variety of in silico tools aid in the interpretation of sequence variants, 
primarily providing a prediction score generated using different algorithms, training cohorts, and 
features16. The three most commonly used missense variant interpretation tools16 include 
PolyPhen28, SIFT10 and Mutation Taster46. While these tools can stratify pathogenic variants 
from benign with a reasonable accuracy (65 – 80%)47, progress has not been made to provide 
users with biologically-relevant features of the location and context of missense variants within 
3D structures. This is a problem in particular for molecular scientists who need a pre-selection 
of variants to study protein function. In this work, besides generating a quantitative score to 
rationalize missense variant pathogenicity, we also provide the relevant features to support the 
candidate variant selection by molecular biologists (Fig. 3). Moreover, the gnomAD cohort has 
been leveraged for the first time in our work to assess genetic burden on protein features. 
MISCAST is also the only resource to date that gives protein functional class-specific 
characterization of missense variants, providing many function-specific structural insights into 
the effect of missense variants at the molecular level. Thus, MISCAST can serve as a powerful 
resource for the translation of personal genomics to precision medicine by translating genetic 
variant into 3D protein context: it can help to delineate variant pathogenicity, select candidate 
variants for functional assay, and aid in generating hypothesis for targeted drug development. 
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Online Methods 
Protein structure and sequence collection. 
The Protein Data Bank (PDB)32 was mined on September 08, 2017 to collect all solved protein three-
dimensional (3D) structures that were fully or partly (chimeric) indexed as homo sapiens. Our initial 
curation resulted in 43,805 protein structures, both single-chain and multiple-chain, including structures 
solved by six different experimental methods. Around 85% of the structures in this collection were solved 
by X-ray crystallography, of which over 50% of the structures in our collection are of resolution greater 
than 2.0 Å. The next highest proportion of the structures (~10%) were solved using nuclear magnetic 
resonance (NMR).   
 From UniProt48, the corresponding protein identifiers and gene name for the 43,805 protein 
structures were collected, which resulted in 5,870 unique protein identifiers and 5,850 unique gene 
names. Mapping of coordinates of amino acid residues in 3D structures to linear protein sequence was 
derived from the SIFTS database49.  
Missense variant collection and mapping on protein structure 
Protein-coding missense variants in the general population were retrieved from the genome aggregation 
Database (gnomAD6) public release 2.0.2. Consolidated files for all available exomes and genomes 
(coding-only subset) were downloaded in Variant Call Format50 (VCFs) 
(http://gnomad.broadinstitute.org/downloads). Missense variant extraction was performed with vcftools 
based on the pre-annotated consequence “CSQ” field (VEP, Ensembl51 v92). All annotations refer to the 
human reference genome version GRCh37.p13/hg19. Entries passing gnomAD standard quality controls 
(Filter = “PASS” flag) and annotated to a canonical transcript were extracted (CSQ canonical = “YES” 
flag). The canonical transcript is defined as the longest CCDS translation with no stop codons according 
to Ensembl51. Exome and genome missense variants calls were consolidated into one single file using in-
house Perl scripts (available upon request) matching identical genomic position and annotation. 
 We retrieved pathogenic missense variants from two sources: the ClinVar database (ClinVar)5, 
February, 2018 release and The Human Gene Mutation Database36 (HGMD®) Professional release 
2017.2. ClinVar variants were downloaded directly from the ftp site (ftp://ftp.ncbi.nlm.nih.gov/pub/clinvar/) 
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in table format. Missense variants were inferred through the analysis of the Human Genome Variation 
Society Sequence Variant Nomenclature field45 (HGVS, e.g. p.Gly1046Arg). To increase stringency, 
ClinVar variants were filtered to have only “Pathogenic” and/or “Likely Pathogenic” clinical consequence. 
Raw HGMD files were directly filtered for missense variants, high confidence calls (hgmd_confidence = 
“HIGH” flag), and disease-causing states (hgmd_variantType = “DM” flag). All annotations refer to the 
human reference genome version GRCh37.p13/hg19. Variants annotated to non-canonical transcripts 
were not considered. 
 Out of 5,850 genes with experimentally solved structures, we had gnomAD, ClinVar and HGMD 
missense variants for 5,724, 1,466 and 1,673 genes, respectively. Altogether, we collected 1,485,579; 
16,570, and 47,036 amino acid alterations by missense variants from gnomAD, ClinVar and HGMD, 
respectively. We filtered out genes for which (i) canonical isoform protein sequences were not translated 
from canonical transcripts and (ii) amino acid residues affected by variants were not mappable to a 
protein structure. Thereafter, we had 496,869 gnomAD (33.4% of available variants), 8,137 ClinVar 
(49.1% of the available variants) and 30,730 HGMD (65.3% of the available variants) missense variants 
or amino acid alterations, respectively, that could be mapped at least one protein structure. Since ClinVar 
and HGMD are not mutually exclusive, we took the union of both resources, which was accomplished by 
comparison of their respective HGVS annotations using an in-house Perl script. Finally, we had 496,869 
gnomAD (referred to as population/control) and 32,923 combined ClinVar and HGMD (referred to as 
pathogenic/case) missense amino acid variations from 4,897 and 1,330 genes, and these variants were 
mapped respectively onto 29,870 and 14,270 protein structures (PDB files). For comparative association 
analysis between population/pathogenic variants with protein features, we have used the 1,330 genes 
(Supplementary Table 1) only for which we had pathogenic (count = 32,923) and population (count = 
164,915) variants. We refer to this dataset as the Disease-Associated Genes with Structure (DAGS1330). 
The full data overview is given in Table 1. The pipeline for mapping variants onto the protein 3D 
structures is shown in Fig. 1. 
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Protein class annotation 
The PANTHER (Protein ANalysis THrough Evolutionary Relationships) database33 was curated to classify 
genes by their molecular function, biological process, and protein class. The PANTHER Protein Class 
ontology was adapted from the PANTHER/X molecular function ontology.  
 We obtained the protein class annotations for 1,330 genes in the DAGS1330 dataset with 
population (gnomAD) and pathogenic (ClinVar and HGMD) variants mapped on the protein 3D structures. 
Initially, the genes were classified into 178 groups based on similar molecular function, 234 groups based 
on their involvement in similar biological processes, and into 206 different protein class groups. Finally, 
guided by the relationships defined among different protein classes (source: 
http://data.pantherdb.org/PANTHER13.1/ontology/Protein_Class_13.0), the genes were grouped into 24 
major protein classes. After automatic annotation, we observed that 624 genes were not assigned to any 
specific protein class and so as to any protein major class. We then downloaded the Ensembl family 
description of all human genes (version 93) using BioMart (https://www.ensembl.org/biomart). After that, 
we manually annotated the 624 genes into those 24 major classes based on (i) the Ensemble family 
description, (ii) molecular function/biological process annotation previously collected from PANTHER or 
(iii) molecular function/biological process annotation available in UniProt as defined by the Gene Ontology 
consortium. Supplementary Table 2 lists the 24 major classes and the number of genes, the number of 
protein 3D structures, and the count of population/pathogenic variants mapped on protein structures for 
each protein class. Note that each gene may not be assigned into a unique protein class group; therefore, 
the genes in each group are not mutually exclusive.  
Feature set mining and annotation 
We annotated the amino acid residues of 1,330 genes with seven different features comprising of 40 
feature subtypes. In the following, we introduce the features and we discuss how we curated these 
features and annotated the amino acid positions in the Supplementary Note. 
1. 3-class secondary structure (subtype count: 3): (1) b-sheet/strand: b-strand and b-sheet; (2) Helices 
310-helix, a-helix, p-helix; (3) Coils – turn, bend, and random loops.  
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2. 8-class secondary structure (subtype count: 8): (1) b-strand; (2) b-sheet; (3) 310-helix; (4) a-helix; (5) 
p-helix; (6) coil: turn; (7) coil: bend; (8) coil: loop.  
3. Residue exposure level (subtype count: 5): (1) core (RSA < 5%); (2) buried (5% ≤ RSA < 25%); (3) 
medium-buried (25% ≤ RSA < 50%); (4) medium-exposed (50% ≤ RSA < 75%); (5) exposed (RSA ≥ 
75%). 
4. Physiochemical properties of amino acids (subtype count: 8): (1) aliphatic – alanine (Ala/A), 
isoleucine (Ile/I), leucine (Leu/L), methionine (Met/M), valine (Val/V); (2) aromatic – phenylalanine 
(Phe/F), tryptophan (Trp/W), tyrosine (Tyr/Y); (3) hydrophobic – aliphatic and aromatic amino acids; 
(4) positively-charged – arginine (Arg/R), histidine (His/H), lysine (Lys/K); (5) negatively-charged – 
aspartic acid (Asp/D), glutamic acid (Glu/E); (6) neutral – asparagine (Asn/N), glutamine (Gln/Q), 
serine (Ser/S), threonine (Thr/T); (7) polar – positively-charged, negatively-charged, and neutral 
amino acids; (8) special – proline (Pro/P), glycine (Gly/G), cystine (Cys/C).  
5. Protein-protein interactions (subtype count: 4): (1) disulfide bond; (2) salt-bridge ionic interaction; (3) 
hydrogen bond; (4) nonbonded van der Waals interaction.  
6. Post-translational modifications (subtype count: 6): (1) acetylation; (2) methylation; (3) O.GlcNAc, 
also known as β-linked N-acetylglucosamine; (4) phosphorylation; (5) SUMOylation; (6) ubiquitination.  
7. UniProt-based functional features (subtype count: 6): (1) functional site – active site, metal binding 
site, binding site, site; (2) functional/binding region – zinc finger, DNA binding region, nucleotide 
phosphate binding region, calcium binding region; (3) sequence motif/region – region, repeat, coiled 
coil, motif; (4) modular domain – domain, topological domain, transmembrane, intramembrane; (5) 
molecular processing associated region – peptide, transit peptide, signal peptide, propeptide; (6) 
modified residue – modified residue, lipidation, disulfide bond, cross-link, glycosylation.  
Statistical analysis  
For each of the 40 subtypes of seven protein features, we carried out the two-tailed Fisher Exact test on 
the 2x2 contingency matrix, populated with the total number of pathogenic and population variants of one 
specific protein feature subtype (helix within 3-class secondary structure) and the rest within a protein 
structure feature-group (‘not helix’ equals to ‘β-strand/sheet and coil’ within 3-class secondary structure). 
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From this test, we obtained an estimate of fold enrichment, referred to as odds ratio (OR), along with the 
95% confidence interval (CI) that shows whether the population/patient variants are relatively enriched or 
depleted in residues of any specific feature type on 3D structure. A value of OR equal to 1 indicates that 
there is no association between a specific type of variant with a particular feature, whereas a value of OR 
greater than 1 (or less than 1) indicates that the pathogenic variants are enriched (or depleted) in a 
particular type of feature subtype. Further, we calculated p-values showing the significance of association 
that were compared to the pcut-off. This analysis was also performed taking variants from all proteins and 
variants from the 24 different protein classes separately, and the output gives the features that are most 
likely to be associated to the pathogenic and population variants in general and also separately in 
different protein types. We defined pcut-off according to the Bonferroni correction for multiple testing in 
statistical analysis, thus pcut-off was set to 5.00e-05 (0.05/(40 * 25)) as we have 40 features on which we 
performed the association analysis taking all proteins and separately for 24 protein classes.  
Implementation of the online resource, MISCAST   
The Missense variant to proteIn StruCture Analysis SuiTe, MISCAST has been made publicly available 
through (http://miscast.broadinstitute.org/). MISCAST was developed with the Shiny framework of R 
studio52. All the two-dimensional plots shown by the online tool are based on the ggplot253 and plotly54 R 
libraries. To visualize the variants on one-dimensional linear protein sequence, we used the multiple 
sequence alignment (MSA) viewer55 (source: http://msa.biojs.net/). To visualize the protein features and 
missense variants simultaneously over the one- and three-dimensional protein structures in our 
application, we utilized ProtVista56 and MolArt57. MolArt is a JavaScript plugin enabling to view sequence 
annotations and overlay them over available 3D experimental or predicted structures. ProtVista56 and 
MolArt57 allows the users to visually inspect the features in the context of the 1D and 3D structures, and 
to contrast them with the variant positions. To support advanced analysis and visualization outside of the 
web environment, MolArt provides the ability to export feature and variant annotated protein structure to 
PyMOL. Further, the missense variant and protein feature annotations are freely downloadable in tab-
delimited text format from MISCAST. 
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Validation of MISCAST-annotations: dataset and method 
An independent pathogenic and benign missense variant set was collected from ClinVar database 
(ClinVar)5, February, 2019 release and The Human Gene Mutation Database36 (HGMD®) Professional 
release 2018.4. The ClinVar benign and likely-benign variants (referred as BLB) was used as the benign 
variant set during validation, including 9,222 variants in 4,489 amino acids. In total, 34,273 amino acid 
positions had ClinVar-annotated pathogenic and likely-pathogenic variants and HGMD-reported disease 
mutations. After removing the positions included in the training set for statistical analysis, 12,004 amino 
acids with 18,094 independent pathogenic variants (referred as PLP) remained the validation set. The 
BLB and PLP validation set contained missense variants in 1,286 genes out of the 1,330 genes. High-
throughput mutagenesis readouts, classifying loss-of-function or damaging substitutions from neutral 
substitutions in exon 13 of BRCA1 and full PTEN protein sequence were collected form literature34,35.  
MISCAST feature difference spectrum (MISCAST-fdspec; Fig 3) was calculated taking the 
difference of the number of pathogenic- and population-variant associated features of a variant position. 
Only the features that had significant associations were considered in the MISCAST-fdspec calculation. 
MISCAST-fdspec > 0 indicate that a reference amino acid has comparatively more pathogenic-variant-
associated features and is thereof more vulnerable to substitution. On the other hand, an amino acid with 
MISCAST-fdspec < 0 is expected to be more tolerant of the substitution. MISCAST-fdspec can be derived 
with protein class-specific or all protein class-based pathogenic- and population-variant-associated 
features. The maximum and minimum values for a specific protein class depends on the number of the 
significant pathogenic- and population-associated features, respectively (Supplementary Table 2). 
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Figure Legends 
Fig. 1 | Flowchart of the study. Genetic variant to protein structure mapping pipeline, feature annotation 
and statistical analysis. 
Fig. 2 | Burden of pathogenic and population variants in protein features, taking 32,923 pathogenic 
and 164,915 population variants in 1,330 genes. The plot shows results of the two-tailed Fisher’s Exact 
test for 40 feature subtypes. The y-axis outlines the feature names, followed by the feature counts with and 
without (yes/no) pathogenic and population variants, the odds ratio (OR) and the significance (p-value). 
The squares (brown) show the OR and the bars (blue) show the 95% confidence interval on the x-axis. 
OR=1 indicates the neutral value (no enrichment or depletion) while the OR > 1.0 (and < 1.0) indicates 
enrichment of pathogenic variants (and population variants). If the association is significant (p-value < pcut-
off = 5.0e-05), the corresponding p-value is followed by (*), otherwise (-). For protein-protein interaction 
types, the feature counts correspond to all bond-annotations available for the amino acid residues with 
pathogenic and population variants. For the rest of the features, the counts correspond to the number of 
amino acid residues. 
 
Fig. 3 | Overview of Missense variant to ProteIn StruCture Analysis web SuiTe (MISCAST). a, 
MISCAST 3D viewer with pathogenic (red) and population (blue) variants in the CDKL5 gene (Cyclin-
dependent kinase-like 5) mapped on its corresponding protein structure (PDB: 4bgq). An additional 
reference amino acid Tyr262 is highlighted in magenta for further analysis in this overview. Features (not 
shown in this figure) and variants can be visualized in 1D and 3D protein structure through MISCAST and 
are freely downloadable for offline analysis. b, Structural, physicochemical and functional feature 
annotations for Tyr262, available in MISCAST. c, Quantitative comparison of protein class-specific 
pathogenic and population-variant-associated feature counts for Tyr262, which are 6 and 0, respectively, 
shown (magenta circle) on the distribution of feature counts obtained by in-training pathogenic and 
population variant set. Thus, for Tyr261, MISCAST-fdspec is equal to 6 – 0 = 6. A positive MISCAST-fdspec 
indicates that Tyr262 possesses higher variant vulnerability. d, Besides quantitative comparison, user can 
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check the original features of Tyr262 that were matched with the protein function-specific features to 
hypothesize the molecular consequence of the Tyr262 substitution.    
 
Fig | 4. Validation of MISCAST-fdspec using clinically-ascertained independent variant set. a, 
Proportion of pathogenic and likely-pathogenic variants from ClinVar and disease mutations from HGMD in 
1,286 genes (referred as PLP), independent from the training set, and benign and likely-benign variants 
from ClinVar (referred as BLB) in different MISCAST-fdspec bands, quantifying the difference between the 
number of pathogenic- and population-variant-associated features. The most confident positive MISCAST-
fdspec band (> 2) contains 4.9-times more PLP than BLB variants and that of confident negative MISCAST-
fdspec band (> 2) contains 4.2-times more BLB and PLP variants. b, Proportion of PLP and BLB variants 
in 249 nucleic acid binding genes in different MISCAST-fdspec bands, computed based on nucleic acid 
binding protein class-specific features. c, Proportion of PLP and BLB variants in 208 transferase genes in 
different MISCAST-fdspec bands, computed based on nucleic acid binding protein class-specific features. 
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